The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialStephen Phillips, Adam Kobayashi, Stefano Ricci et al.|The Lancet|2012Cited by 1.2k
Five-Year Risk of Stroke after TIA or Minor Ischemic StrokePierre Amarenco, Ka Sing Wong, Philippa C. Lavallée et al.|New England Journal of Medicine|2018Cited by 363
Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomesManuel Correia, Luı́s F. Maia, Isabel Silva et al.|European Journal of Neurology|2022Cited by 32
Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic StrokeRicardo Varela, Luı́s F. Maia, Fernando González‐Ortiz et al.|Stroke|2024Cited by 14
ABSTRACT NUMBER: ESOC2026A2417 POSTPROCEDURAL GFAP PREDICTS CLINICALLY RELEVANT HEMORRHAGIC TRANSFORMATION AFTER ENDOVASCULAR THROMBECTOMYRicardo Varela, Luís Maia, Liliana Igreja et al.|European Stroke Journal|2026Cited by 0